Skip to main content
Log in

Upregulated DJ-1 promotes renal tubular EMT by suppressing cytoplasmic PTEN expression and Akt activation

  • Published:
Journal of Huazhong University of Science and Technology [Medical Sciences] Aims and scope Submit manuscript

Summary

Recently, phosphatase and tensin homolog deleted on chromosome 10 (PTEN) is suggested as a new agent in the fighting against fibrogenesis. In tumor, DJ-1 is identified as a negative regulator of PTEN. But the expression of DJ-1 and the regulation of PTEN in fibrosis are unclear. Renal fibrosis was induced in 5/6 subtotal nephrectomy rat model. Human proximal tubular epithelial cells (HKC) were treated with transforming growth factor-beta 1 (TGF-β1), or transfected with DJ-1 or PTEN. Confocal microscope was used to investigate the localization of DJ-1 and PTEN. The selective phosphoinositide-3 kinase (PI3K) inhibitor, LY294002, was administered to inhibit PI3K pathway. The DJ-1 and PTEN expression, markers of epithelial-mesenchymal transition (EMT) and Akt phosphorylation were measured by RT-PCR, Western blotting or immunocytochemistry. In vitro, after HKC cells were stimulated with 10 ng/mL TGF-β1 for 72 h, the expression of DJ-1 was increased, and that of PTEN was decreased. In vivo, the same results were identified in 5/6-nephrectomized rats. In normal HKC cells, most of DJ-1 protein localized in cytoplasm, and little in nucleus. TGF-β1 upregulated DJ-1 expression in both cytoplasma and nuclei. In contrary, TGF-β1 emptied cytoplasmic PTEN protein into nucleus. Overexpression of DJ-1 decreased the expression of PTEN, promoted the activation of Akt and the expression of vimentin, and also led to the loss of cytoplasmic PTEN. Contrarily, overexpression of PTEN protected HKC cells from TGF-β1-induced EMT. In conclusion, DJ-1 is upregulated in renal fibrosis and DJ-1 mediates EMT by suppressing cytoplasmic PTEN expression and Akt activation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Eddy AA. Molecular basis of renal fibrosis. Pediatr Nephrol, 2000,15(34):290–301

    Article  PubMed  CAS  Google Scholar 

  2. Razzaque MS, Taguchi T. Cellular and molecular events leading to renal tubulointerstitial fibrosis. Med Electron Microsc, 2002,35(2):68–80

    Article  PubMed  CAS  Google Scholar 

  3. Kallui R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest, 2003, 112(12):1776–1784

    Google Scholar 

  4. Tamura M, Gu J, Matsumoto K, et al. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science, 1998,280(5369):1614–1617

    Article  PubMed  CAS  Google Scholar 

  5. Maehama T, Dixon JE. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3, 4, 5-trisphosphate. J Biol Chem, 1998,273(22):13 375–13 378

    Article  CAS  Google Scholar 

  6. Gu J, Tamura M, Pankov R, et al. Shc and FAK differentially regulate cell motility and directionality modulated by PTEN. J Cell Biol, 1999,146(2):389–403

    Article  PubMed  CAS  Google Scholar 

  7. Kwak YG, Song CH, Yi HK, et al. Involvement of PTEN in airway hyperresponsiveness and inflammation in bronchial asthma. J Clin Invest, 2003,111(7):1083–1092

    PubMed  CAS  Google Scholar 

  8. White ES, Thannickal VJ, Carskadon SL, et al. Integrin α4β1 regulates migration across basement membranes by lung fibroblasts: a role for phosphatase and tensin homologue deleted on chromosome 10. Am J Respir Crit Care Med, 2003,168(4):436–442

    Article  PubMed  Google Scholar 

  9. White ES, Atrasz RG, Hu B, et al. Negative regulation of myofibroblast differentiation by PTEN (phosphatase and tensin homolog deleted on chromosome 10). Am J Respir Crit Care Med, 2006,173(1):112–121

    Article  PubMed  CAS  Google Scholar 

  10. Mahimainathan L, Das F, Venkatesan B, et al. Mesangial cell hypertrophy by high glucose is mediated by down-regulation of the tumor suppressor PTEN. Diabetes, 2006,55(7):2115–2125

    Article  PubMed  CAS  Google Scholar 

  11. Fu SX, Zhang K, Tan HB, et al. Effect of tumor suppressor PTEN on tubulointerstitial fibrosis (TIF) in IgA. Nephrology, 2008,13:11

    Google Scholar 

  12. Li DM, Sun H. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res, 1997,57(11):2124–2129

    PubMed  CAS  Google Scholar 

  13. Bonifati V, Rizzu P, van Baren MJ, et al. Mutations in the DJ-1 gene associated with autosomal recessive early-onset Parkinsonism. Science, 2003,299(5604):256–259

    Article  PubMed  CAS  Google Scholar 

  14. Le Naour F, Misek DE, Krause MC, et al. Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer. Clin Cancer Res, 2001, 7(11):3328–3335

    PubMed  Google Scholar 

  15. Mackeigan JP, Clements CM, Lich JD, et al. Proteomic profiling drug-induced apoptosis in non-small cell lung carcinoma: identification of RS/DJ-1 and RhoGDIalpha. Cancer Res, 2003,63(20):6928–6934

    PubMed  CAS  Google Scholar 

  16. Grzmil M, Voigt S, Thelen P, et al. Up-regulated expression of the MAT-8 gene in prostate cancer and its siRNA-mediated inhibition of expression induces a decrease in proliferation of human prostate carcinoma cells. Int J Oncol, 2004,24(1):97–105

    PubMed  CAS  Google Scholar 

  17. Davidson B, Hadar R, Schlossberg R, et al. Expression and clinical role of DJ-1, a negative regulator of PTEN in ovarian carcinoma. Hum Pathol, 2008,39(1):87–95

    Article  PubMed  CAS  Google Scholar 

  18. Kim RH, Peters M, Jang YJ, et al. DJ-1, a novel regulator of the tumor suppressor PTEN. Cancer Cell, 2005,7(3): 263–273

    Article  PubMed  CAS  Google Scholar 

  19. Ge S, Zeng R, Luo Y, et al. Role of protein kinase C in advanced glycation end products-induced epithelial-mesenchymal transition in renal proximal tubular epithelial cells. J Huazhong Univ Sci Technolog Med Sci, 2009, 29(3):281–285

    Article  PubMed  CAS  Google Scholar 

  20. Luo XU, Yang Q, Zhang Q, et al. Differential analysis of associated proteome in hepatic fibrosis tissue. Zhonghua Yi Xue Za Zhi (Chinese), 2007,87(48):3411–3414

    CAS  Google Scholar 

  21. Fan JM, Ng YY, Hill PA, et al. Transforming growth factor-beta regulated tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney Int, 1999,56(4):1455–1467

    Article  PubMed  CAS  Google Scholar 

  22. Wang X, Trotman LC, Koppie T, et al. NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN. Cell, 2007, 128(1):129–139

    Article  PubMed  CAS  Google Scholar 

  23. Gimm O, Perren A, Weng LP, et al. Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors. Am J Pathol, 2000,156(5):1693–1700

    Article  PubMed  CAS  Google Scholar 

  24. Perren A, Weng LP, Boag AH, et al. Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast. Am J Pathol, 1999,155(4):1253–1260

    Article  PubMed  CAS  Google Scholar 

  25. Virolle T, Adamson ED, Baron V, et al. The Egr-1 transcription factor directly activates PTEN during irradiation-induced signaling. Nat Cell Biol, 2001,3(12):1124–1128

    Article  PubMed  CAS  Google Scholar 

  26. Stambolic V, MacPherson D, Sas D, et al. Regulation of PTEN transcription by p53. Mol Cell, 2001,8(2):317–325

    Article  PubMed  CAS  Google Scholar 

  27. Patel L, Pass I, Coxon P, et al. Tumor suppressor and anti-inflammatory actions of PPARgamma agonists are mediated via upregulation of PTEN. Curr Biol, 2001,11(10):764–768

    Article  PubMed  CAS  Google Scholar 

  28. Xia D, Srinivas H, Ahn YH, et al. Mitogen-activated protein kinase kinase-4 promotes cell survival by decreasing PTEN expression through an NF kappa B-dependent pathway. J Biol Chem, 2007,282(6):3507–3519

    Article  PubMed  CAS  Google Scholar 

  29. Quiroz Y, Bravo J, Herrera-Acosta J, et al. Apoptosis and NFkappaB activation are simultaneously induced in renal tubulointerstitium in experimental hypertension. Kidney Int Suppl, 2003,86:S27–32

    Article  PubMed  CAS  Google Scholar 

  30. Burgering BM, Coffer PJ. Protein kinase B (c-Akt) in phospha-tidylinositol-3-OH kinase signal transduction. Nature, 1995,376(6541):599–602

    Article  PubMed  CAS  Google Scholar 

  31. Fruman DA, Meyers RE, Cantley LC. Phosphoinositide kinases. Annu Rev Biochem, 1998,67:481–507

    Article  PubMed  CAS  Google Scholar 

  32. Alessi DR, James SR, Downes CP, et al. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase. Balpha Curr Biol, 1997,7(4):261–269

    Article  CAS  Google Scholar 

  33. Sun H, Lesche R, Li DM, et al. PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3, 4, 5,-trisphosphate and Akt/protein kinase B signaling pathway. Proc Natl Acad Sci USA, 1999,96(11):6199–6204

    Article  PubMed  CAS  Google Scholar 

  34. Chung JH, Eng C. Nuclear-cytoplasmic partitioning of phosphatase and tensin homologue deleted on chromosome 10 (PTEN) differentially regulates the cell cycle and apoptosis. Cancer Res, 2005,65(18):8096–8100

    Article  PubMed  CAS  Google Scholar 

  35. Roura S, Miravet S, Piedra J, et al. Regulation of E-cadherin/catenin association by tyosine phosphorylation. J Biol Chem, 1999,274(51):36 734–36 740

    Article  CAS  Google Scholar 

  36. Han M, Xu G, Zeng R, et al. Tyrosine phosphorylation of β-catenin modulates the expression of E-cadhein in the epithelial-mesenchymal transition induced by TGF-β. Chin J Nephrol, 2006,22(8):494–498

    CAS  Google Scholar 

  37. Kattla JJ, Carew RM, Heljic M, et al. Protein kinase B/Akt activity is involved in renal TGFta-1 driven epithelial-mesenchymal transition in vitro and in vivo. Am J Physiol Renal Physiol, 2008,295(1):F215–225

    Google Scholar 

  38. Kuwano K. PTEN as a new agent in the fight against fibrogenesis. Am J Respir Crit Care Med, 2006,173(1):5–6

    Article  PubMed  Google Scholar 

  39. Tan EK, Tan C, Zhao Y, et al. Genetic analysis of DJ-1 in cohort Parkinson’s disease patients of different ethnicity. Neurosci Lett, 2004,367(1):109–112

    Article  PubMed  CAS  Google Scholar 

  40. Sekito A, Taira T, Niki T, et al. Stimulation of transforming activity of DJ-1 by Abstrakt, a DJ-1-binding protein. Int J Oncol, 2005,26(3):685–689

    PubMed  CAS  Google Scholar 

  41. Blokhina O, Virolainen E, Fagerstedt KV. Antioxidants, oxidative damage and oxygen deprivation stress: A review. Ann Bot (Lond), 2003,91:179–194

    Article  CAS  Google Scholar 

  42. Nangaku M. Chronic hypoxia and tubulointerstitial injury: A final common pathway to end-stage renal failure. J Am Soc Nephrol, 2006,17(1):17–25

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gang Xu  (徐 钢).

Additional information

Both authors contributed equally to this work.

This work was supported by a grant from National Natural Sciences Foundation of China (No. 30800525).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yao, Y., Wei, H., Liu, L. et al. Upregulated DJ-1 promotes renal tubular EMT by suppressing cytoplasmic PTEN expression and Akt activation. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 31, 469–475 (2011). https://doi.org/10.1007/s11596-011-0475-3

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11596-011-0475-3

Key words

Navigation